🔎 Trials Near Me

Dachaigh › Leukemia lymphoblastic geur › Texas › Houston

Sgrùdaidhean clionaigeach Leukemia lymphoblastic geur ann an Houston, TX

Tha 28 sgrùdaidhean airson Leukemia lymphoblastic geur a’ lorg phàirtichean aig làraichean ann agus timcheall air Houston (taobh a-staigh mu 30 mìle). Fosglaidh sgrùdadh gus faicinn cò as urrainn pàirt a ghabhail agus mar a chuireas tu fios air an sgioba.

Teacsa sgrùdaidh oifigeil (Beurla)

A’ fastadh airson sgrùdadh an seo? Seall e aig mullach na duilleige seo — $99 airson 30 latha →

Activated T-Cells Expressing 2nd or 3rd Generation CD19-Specific CAR, Advanced B-Cell NHL, ALL, and CLL (SAGAN)

A’ fastadhÌre 1
  • Houston Methodist Hospital, Houston
  • Texas Children's Hospital, Houston
Suas gu aois 75 · Gach gnè · Air ùrachadh 2 Dàmh 2026 · NCT01853631

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

A’ fastadhSgrùdadh amharcFàilte do shaor-thoilich fhallain
  • UT MD Anderson Cancer Center, Houston
Aoisean 40 gu 75 · Gach gnè · Air ùrachadh 2 Dàmh 2026 · NCT05334069

Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution

A’ fastadhSgrùdadh amharc
  • Texas Children's Hospital, Houston
Aoisean 0 gu 38 · Gach gnè · Air ùrachadh 1 Dàmh 2026 · NCT06131801

A Phase 1 Study of Orca-Q in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies

A’ fastadhÌre 1
  • University of Texas MD Anderson Cancer Center, Houston
Aoisean 12 gu 78 · Gach gnè · Air ùrachadh 29 Sult 2026 · NCT03802695

A Phase 2 Study of WU-CART-007, an Anti-CD7 Allogeneic CAR-T Cell Therapy in T-Cell Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma (T-RRex)

A’ fastadhÌre 2
  • MD Anderson Cancer Center, Houston
6 Months · Gach gnè · Air ùrachadh 28 Sult 2026 · NCT06514794

Evaluating the Relationship Between Skin Color and Pulse Oximeter Accuracy in Children

A’ fastadhSgrùdadh amharc
  • Texas Children's Hospital, Houston
4 Weeks – 18 Years · Gach gnè · Air ùrachadh 24 Sult 2026 · NCT06529575

Phase I/II Study of the Combination of Blinatumomab and Asciminib in Patients With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

A’ fastadhÌre 1/2
  • MD Anderson Cancer Center, Houston
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 23 Sult 2026 · NCT06308588

The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study

A’ fastadhÌre 1/2
  • Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center, Houston
  • UT MD Anderson Cancer Center, Houston
Suas gu aois 22 · Gach gnè · Air ùrachadh 25 Lùna 2026 · NCT04726241

Caloric Restriction and Activity to Reduce Chemoresistance in B-ALL

A’ fastadhÌre 2
  • Baylor Texas Children's Hospital, Houston
Aoisean 7 gu 25 · Gach gnè · Air ùrachadh 19 Lùna 2026 · NCT05082519

A Study of CTD402 in T-ALL/LBL Patients

A’ fastadhÌre 1/2
  • MD Anderson Cancer Center, Houston
Aoisean 1 agus nas sine · Gach gnè · Air ùrachadh 19 Lùna 2026 · NCT07070219

Safety Study to Evaluate the Occurrence of EFAD in Pediatric Patients With PNAC Who Require More Than Eight Weeks of Omegaven Treatment

A’ fastadhSgrùdadh amharc
  • Baylor College of Medicine Houston, Houston
1 Day – 17 Years · Gach gnè · Air ùrachadh 14 Lùna 2026 · NCT06274788

Phase 2 Study Assessing the Clinical Activity and Safety of Obecabtagene Autoleucel as a Consolidation in Patients With Newly Diagnosed High-risk B-cell Acute Lymphocytic Leukemia (ALL)

A’ fastadhÌre 2
  • The University of Texas M. D. Anderson Cancer Center, Houston
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 12 Lùna 2026 · NCT07053059

Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma, Burkitt Lymphoma/Leukemia, or Double-Hit Lymphoma/Leukemia

A’ fastadhÌre 2
  • M D Anderson Cancer Center, Houston
Aoisean 15 agus nas sine · Gach gnè · Air ùrachadh 10 Lùna 2026 · NCT03136146

Personalized NK Cell Therapy in CBT

A’ fastadhÌre 2
  • M D Anderson Cancer Center, Houston
Aoisean 15 gu 80 · Gach gnè · Air ùrachadh 30 Iuch 2026 · NCT02727803

Study of AZD4512 Monotherapy or in Combination With Anticancer Agents in Participants With Acute Lymphoblastic Leukemia

A’ fastadhÌre 1/2
  • Research Site, Houston
Aoisean 12 agus nas sine · Gach gnè · Air ùrachadh 13 Iuch 2026 · NCT07109219

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

A’ fastadhSgrùdadh amharc
  • M.D. Anderson Cancer Center, Houston
  • Texas Children's Hospital - Baylor Medical Center, Houston
Gach aois · Gach gnè · Air ùrachadh 6 Iuch 2026 · NCT01351545

A Study of Revumenib and Mezigdomide in People With Leukemia

A’ fastadhÌre 1/2
  • MD Anderson Cancer Center (Data Collection Only), Houston
Aoisean 12 agus nas sine · Gach gnè · Air ùrachadh 22 Ògmh 2026 · NCT07356154

TINI 2: Total Therapy for Infants With Acute Lymphoblastic Leukemia II

A’ fastadhÌre 1/2
  • MD Anderson, Houston
Suas gu aois 1 · Gach gnè · Air ùrachadh 3 Ògmh 2026 · NCT05848687

Blinatumomab, Methotrexate, Cytarabine, and Ponatinib in Treating Patients With Philadelphia Chromosome-Positive, or BCR-ABL Positive, or Relapsed/Refractory, Acute Lymphoblastic Leukemia

A’ fastadhÌre 2
  • M D Anderson Cancer Center, Houston
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 20 Cèit 2026 · NCT03263572

Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment

A’ fastadhSgrùdadh amharc
  • Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center, Houston
Gach aois · Gach gnè · Air ùrachadh 18 Cèit 2026 · NCT01790152

Study of Oral Administration of LP-118 in Patients With Relapsed or Refractory CLL, SLL, MDS, MDS/MPN, AML, CMML-2, MPN-BP, ALL, MF, NHL, RT, MM or T-PLL.

A’ fastadhÌre 1
  • MD Anderson Cancer Center, Houston
Aoisean 13 agus nas sine · Gach gnè · Air ùrachadh 5 Cèit 2026 · NCT04771572

A Study of Olverembatinib in Patients With Newly Diagnosed Ph+ ALL (POLARIS-1)

A’ fastadhÌre 3
  • Ascentage Investigative Site #1501, Houston
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 30 Gibl 2026 · NCT06051409

A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)

A’ fastadhÌre 1/2
  • MDACC, Houston
Aoisean 12 agus nas sine · Gach gnè · Air ùrachadh 24 Màrt 2026 · NCT04988555

Study of HQP1351 in Subjects With Refractory CML and Ph+ ALL

A’ fastadhÌre 1
  • University of Texas MD Anderson Cancer Center, Houston
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 5 Samh 2025 · NCT04260022

Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies

A’ fastadhÌre 1
  • Texas Children's Hospital/Baylor College of Medicine, Houston
Aoisean 1 gu 21 · Gach gnè · Air ùrachadh 6 Dùbh 2024 · NCT05476770

Sgrùdaidhean Leukemia lymphoblastic geur ann am bailtean eile

Sgrùdaidhean eile ann an Houston

Bho ClinicalTrials.gov, dàta air a thogail 5 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.